Cas:2088-71-3 TESTOSTERONE BENZOATE manufacturer & supplier

Chemical Name:TESTOSTERONE BENZOATE

CAS.NO:2088-71-3

Synonyms:TESTOSTERONE 17-BENZOATE VETRANAL;Testosterone-d3 Benzoate;MFCD00046257;Testosterone, benzoate;Androst-4-en-3-one, 17- (benzoyloxy)-, (17β)-;Stanolone-17-bebzoate;Testosterone benzoate;(17β)-3-Oxoandrost-4-en-17-yl benzoate;Androst-4-en-3-one, 17-(benzoyloxy)-, (17β)-;EINECS 218-232-8;17-O-Benzoyltestosterone

Molecular Formula:C₂₆H₃₂O₃

Molecular Weight:392.530

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:522.4±50.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.583

PSA:43.37000

Exact Mass:392.235138

LogP:6.39

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like TESTOSTERONE 17-BENZOATE VETRANAL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,17-O-Benzoyltestosterone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 218-232-8 Use and application,Testosterone-d3 Benzoate technical grade,usp/ep/jp grade.

Related News: Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. TESTOSTERONE BENZOATE manufacturer The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments. TESTOSTERONE BENZOATE supplier In order to find answers to these questions, our staff in the development department set about conducting a series of experiments. TESTOSTERONE BENZOATE vendor Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. TESTOSTERONE BENZOATE factory The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.